That's not true. The act is that they simply do not have enough evidence backing teh product to make it a standard in hospitals. The case is simply not convincing enough. If it was convincing the NHS would have bought it. I note that it is not standard in Australia either where it was created. There is not a compelling enough case to warrant the additional cost to the system hence it is not funded.
- Forums
- ASX - By Stock
- OSP
- Ann: Quarterly Results and Investor Conference Call Notification
Ann: Quarterly Results and Investor Conference Call Notification, page-25
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online